Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Assets (2023 - 2025)

Historic Assets for Medical Group Holdings (SBC) over the last 3 years, with Q3 2025 value amounting to $321.4 million.

  • Medical Group Holdings' Assets rose 839.34% to $321.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $321.4 million, marking a year-over-year increase of 839.34%. This contributed to the annual value of $266.1 million for FY2024, which is 281.21% up from last year.
  • According to the latest figures from Q3 2025, Medical Group Holdings' Assets is $321.4 million, which was up 839.34% from $315.3 million recorded in Q2 2025.
  • Medical Group Holdings' Assets' 5-year high stood at $321.4 million during Q3 2025, with a 5-year trough of $19.5 million in Q2 2024.
  • Moreover, its 3-year median value for Assets was $262.4 million (2023), whereas its average is $192.4 million.
  • Its Assets has fluctuated over the past 5 years, first plummeted by 8365.42% in 2024, then surged by 151478.21% in 2025.
  • Medical Group Holdings' Assets (Quarter) stood at $258.8 million in 2023, then rose by 2.81% to $266.1 million in 2024, then increased by 20.78% to $321.4 million in 2025.
  • Its Assets was $321.4 million in Q3 2025, compared to $315.3 million in Q2 2025 and $284.6 million in Q1 2025.